IDDF2024-ABS-0215 Acid-suppressing drugs alter microbial composition in peripancreatic fluid collection – a randomized controlled trial

<h3>Background</h3> Infection is still one of the common adverse events after endoscopic drainage of peripancreatic effusion. Acid-suppressive drugs can inhibit pancreatic exocrine and are widely used in patients with pancreatitis. Acid-suppressing drugs affect intestinal microbes by inhibiting the secretion of stomach acid. However, it is not clear whether acid-suppressive drugs affect the microorganisms in the peripancreatic effusion and affect the postoperative complications. <h3>Methods</h3> This study was a randomized, placebo-controlled, double-blind clinical trial. This trial enrolled 45 patients at our medical center. All patients were divided into an acid-inhibited group and a non-acid-inhibited group. In the acid-suppressive group, patients received acid-suppressive medication (omeprazole 80mg intravenously) 7 days before endoscopic drainage. In the non-acid inhibition group, patients received a placebo (intravenous saline administration) starting 7 days before the endoscopic transmural drainage procedure. The main outcome of our study was to observe the difference in microbiota in the two groups of cyst fluid. <h3>Results</h3> A total of 25 patients were included in the acid-inhibited group and 20 patients were included in the non-acid-inhibited group. The two groups were well-matched in terms of demographic characteristics, etiology of pancreatitis, cyst types, and cyst locations. Both groups achieved similar rates of clinical success and technical success (p&gt;0.05). There were no significant differences between the two groups in terms of postoperative infection, bleeding, and recurrence rates (p&gt;0.05). In terms of postoperative C-reactive protein levels, the acid-suppressing group was significantly higher than the non-acid-suppressing group (p&lt;0.05). We conducted 16S microbial sequencing analysis to investigate the microbial composition in the cyst fluid, and we found no significant difference in α diversity between the antibiotic group and the non-antibiotic group. However, there was a significant difference in β diversity analysis between the two groups. <h3>Conclusions</h3> Acid-suppressing drugs can change the microbial composition of pancreatic effusion, which may potentially affect the infection after endoscopic drainage.

Authors

Institutions

Publication Details

Published
2024-08-01
DOI
https://doi.org/10.1136/gutjnl-2024-iddf.88
Primary Topic
Pancreatitis Pathology and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IDDF2024-ABS-0215 Acid-suppressing drugs alter microbial composition in peripancreatic fluid collection – a randomized controlled trial

Senlin Hou, Yaoting Li, Lichao Zhang, Tingting Yu
Pancreatitis Pathology and Treatment
article

IDDF2024-ABS-0215 Acid-suppressing drugs alter microbial composition in peripancreatic fluid collection – a randomized controlled trial

Senlin Hou, Yaoting Li, Lichao Zhang, Tingting Yu
article en

Abstract

<h3>Background</h3> Infection is still one of the common adverse events after endoscopic drainage of peripancreatic effusion. Acid-suppressive drugs can inhibit pancreatic exocrine and are widely used in patients with pancreatitis. Acid-suppressing drugs affect intestinal microbes by inhibiting the secretion of stomach acid. However, it is not clear whether acid-suppressive drugs affect the microorganisms in the peripancreatic effusion and affect the postoperative complications. <h3>Methods</h3> This study was a randomized, placebo-controlled, double-blind clinical trial. This trial enrolled 45 patients at our medical center. All patients were divided into an acid-inhibited group and a non-acid-inhibited group. In the acid-suppressive group, patients received acid-suppressive medication (omeprazole 80mg intravenously) 7 days before endoscopic drainage. In the non-acid inhibition group, patients received a placebo (intravenous saline administration) starting 7 days before the endoscopic transmural drainage procedure. The main outcome of our study was to observe the difference in microbiota in the two groups of cyst fluid. <h3>Results</h3> A total of 25 patients were included in the acid-inhibited group and 20 patients were included in the non-acid-inhibited group. The two groups were well-matched in terms of demographic characteristics, etiology of pancreatitis, cyst types, and cyst locations. Both groups achieved similar rates of clinical success and technical success (p&gt;0.05). There were no significant differences between the two groups in terms of postoperative infection, bleeding, and recurrence rates (p&gt;0.05). In terms of postoperative C-reactive protein levels, the acid-suppressing group was significantly higher than the non-acid-suppressing group (p&lt;0.05). We conducted 16S microbial sequencing analysis to investigate the microbial composition in the cyst fluid, and we found no significant difference in α diversity between the antibiotic group and the non-antibiotic group. However, there was a significant difference in β diversity analysis between the two groups. <h3>Conclusions</h3> Acid-suppressing drugs can change the microbial composition of pancreatic effusion, which may potentially affect the infection after endoscopic drainage.

Hebei Medical University (CN), Second Hospital of Hebei Medical University (CN)
Good health and well-being
Openalex Percentile: Top 76%
Pancreatitis Pathology and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.